ZLAB (Zai Lab) 5-Year EBITDA Growth Rate: 20.10% (As of Mar. 2026)


ZLAB Zai Lab Ltd ZLAB
64 GF Score
Price $19.14
GF Value $30.26
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is Zai Lab 5-Year EBITDA Growth Rate?

Zai Lab ZLAB -0.21% 64 5-Year EBITDA Growth Rate is 20.10% as of Mar. 2026. GuruFocus rates ZLAB with a GF Score™ of 64/100 and a GF Value™ of $30.26 (Possible Value Trap). The stock has 8 warning signs investors should review.

Zai Lab's EBITDA per Share for the three months ended in Mar. 2026 was $-0.40.

During the past 3 years, the average EBITDA Per Share Growth Rate was 31.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 20.10% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -14.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 11 years, the highest 3-Year average EBITDA Per Share Growth Rate of Zai Lab was 31.70% per year. The lowest was -99.20% per year. And the median was -14.75% per year.

Zai Lab  (NAS:ZLAB) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Zai Lab 5-Year EBITDA Growth Rate Related Terms

ZLAB vs STOK, ADMA, VRDN: 5-Year EBITDA Growth Rate Comparison

For the Biotechnology subindustry, Zai Lab's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zai Lab 5-Year EBITDA Growth Rate vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zai Lab's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Zai Lab's 5-Year EBITDA Growth Rate falls into.


ZLAB
64GF Score
Zai Lab Ltd ZLAB
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zai Lab 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 20.10% mean?
Zai Lab (ZLAB) has a 5-Year EBITDA Growth Rate of 20.10% as of Mar. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Zai Lab and its competitors.
Is Zai Lab's 5-Year EBITDA Growth Rate too high?
Zai Lab's current 5-Year EBITDA Growth Rate is 20.10%. Overall, Zai Lab has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Zai Lab's 5-Year EBITDA Growth Rate compare to STOK and ADMA?
Zai Lab's 5-Year EBITDA Growth Rate of 20.10% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Biotechnology company?
A good 5-Year EBITDA Growth Rate depends on the Biotechnology industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Zai Lab and its competitors. Zai Lab's current 5-Year EBITDA Growth Rate is 20.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zai Lab stock overvalued right now?
Based on GuruFocus' analysis, Zai Lab (ZLAB) is currently considered Possible Value Trap. The stock's GF Value™ is $30.26, compared to a current price of $19.14 — trading 36.8% below its estimated fair value. The current 5-Year EBITDA Growth Rate is 20.10%. Zai Lab's overall GF Score™ is 64/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Zai Lab (ZLAB), the current 5-Year EBITDA Growth Rate is 20.10% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zai Lab (ZLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Zai Lab stock appears to be undervalued. The current stock price of $19.14 is trading 36.8% below its estimated GF Value™ of $30.26. GuruFocus considers Zai Lab to be Possible Value Trap.

Key valuation signals for ZLAB:

  • 5-Year EBITDA Growth Rate: 20.10%
  • GF Value™: $30.26 vs. price of $19.14 (36.8% below fair value)
  • GF Score™: 64/100 with 8 warning signs

No single metric tells the full story. See the ZLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zai Lab Business Description

Other Exchanges 09688:Hong Kong1ZLB:Germany
Address 899 Halei Road, Building B, Pudong, Shanghai, CHN, 201203
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
64GF Score

Get the complete analysis for ZLAB

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$19.14
Price
$30.26
GF Value